Seelos Therapeutics, Inc.
SEEL · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $294 | $524 | $2,996 | $2,584 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $188 | $968 | $763 | $221 |
| Inventory | $0 | $0 | $0 | $3,330 |
| Other Curr. Assets | $147 | $115 | $77 | $53 |
| Total Curr. Assets | $2,334 | $3,550 | $5,403 | $6,188 |
| Property Plant & Equip (Net) | $47 | $62 | $15 | $30 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $47 | $62 | $15 | $30 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,381 | $3,612 | $5,418 | $6,218 |
| Liabilities | – | – | – | – |
| Payables | $15,686 | $15,268 | $16,403 | $9,320 |
| Short-Term Debt | $10,157 | $13,075 | $14,213 | $15,604 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $6,340 |
| Other Curr. Liab. | $4,153 | $3,787 | $5,837 | $5,153 |
| Total Curr. Liab. | $30,514 | $36,716 | $38,928 | $35,327 |
| LT Debt | $0 | $0 | $0 | $1,303 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $1,303 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $47 | $62 | $15 | $31 |
| Total Liabilities | $30,514 | $36,716 | $38,928 | $36,630 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $15 | $10 | $159 |
| Retained Earnings | -$253,580 | -$255,290 | -$252,626 | -$247,173 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | -$0 | $0 | $0 | $0 |
| Total Equity | -$28,133 | -$33,104 | -$33,510 | -$30,412 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,381 | $3,612 | $5,418 | $6,218 |
| Net Debt | $9,863 | $12,551 | $11,217 | $14,323 |